KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 118 filers reported holding KRYSTAL BIOTECH INC in Q1 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $520,492 | +9.9% | 4,487 | +11.2% | 0.00% | 0.0% |
| Q2 2023 | $473,709 | +116.2% | 4,035 | +47.4% | 0.00% | +100.0% |
| Q1 2023 | $219,124 | -15.1% | 2,737 | -16.0% | 0.00% | 0.0% |
| Q4 2022 | $258,020 | -9.5% | 3,257 | -20.3% | 0.00% | -50.0% |
| Q3 2022 | $285,000 | +6.3% | 4,089 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $268,000 | -2.2% | 4,089 | -0.9% | 0.00% | +100.0% |
| Q1 2022 | $274,000 | -14.1% | 4,125 | -9.4% | 0.00% | -50.0% |
| Q4 2021 | $319,000 | +538.0% | 4,555 | +378.5% | 0.00% | – |
| Q3 2021 | $50,000 | -21.9% | 952 | +1.2% | 0.00% | – |
| Q2 2021 | $64,000 | -7.2% | 941 | +4.3% | 0.00% | – |
| Q1 2021 | $69,000 | – | 902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |